Suppr超能文献

使用钙阻滞剂使心肌停搏。

Cardioplegic arrest of the myocardium with calcium blocking agents.

作者信息

Balderman S C, Schwartz K, Aldrich J, Chan A K

机构信息

Department of Cardiothoracic Surgery, State University of New York, Buffalo.

出版信息

J Cardiovasc Pharmacol. 1992 Jan;19(1):1-9. doi: 10.1097/00005344-199201000-00001.

Abstract

This study was designed to compare the effects of the calcium slow channel blocking agents verapamil (0.15 mg/kg), diltiazem (0.15 mg/kg), and nifedipine (50 micrograms/kg) on the myocardium after global ischemia and reperfusion in the in situ canine model. Animals were subjected to 120-min normothermic global ischemia, followed by 45-min reperfusion. Cardioplegic arrest of the myocardium was achieved by administering one of the three calcium antagonists in a multidose fashion. Superior preservation (p less than 0.01) of left ventricular (LV) systolic function was achieved in group I (verapamil cardioplegia). dP/dt, at an intraventricular balloon volume of 25 cc, was 83% of control after reperfusion in group I. Group II (diltiazem) and group III (nifedipine) achieved only 55 and 63% of their preischemic dP/dt values. LV chamber stiffness was increased in hearts protected with nifedipine. The exponential constant m was increased from 0.04 +/- 0.01 to 0.08 +/- 0.01. Coronary blood flow after reperfusion increased from 120 to 184 cc/100 gr/min in group I (p less than 0.01). The hyperemic response in group III was negligible. The O2 consumption of the reperfused myocardium was not significantly altered in any of the treatment groups. Lactate metabolism during ischemia and after reperfusion was similar in all groups. ATP values were markedly reduced in all groups (p less than 0.05). Immediately after ischemia, ATP was 50, 28, and 44% of control in group I, II, and III, respectively. The excellent preservation of systolic function and a physiologic hyperemic response by verapamil could not be correlated with improved preservation of high-energy compounds or with significant changes in myocardial O2 consumption.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

本研究旨在比较钙慢通道阻滞剂维拉帕米(0.15毫克/千克)、地尔硫䓬(0.15毫克/千克)和硝苯地平(50微克/千克)对犬原位模型全心缺血及再灌注后心肌的影响。动物接受120分钟常温全心缺血,随后进行45分钟再灌注。通过多剂量给予三种钙拮抗剂之一实现心肌停搏。在I组(维拉帕米心肌停搏)中左心室(LV)收缩功能得到了更好的保存(p<0.01)。在I组中,再灌注后心室内球囊体积为25立方厘米时的dp/dt为对照组的83%。II组(地尔硫䓬)和III组(硝苯地平)仅分别达到缺血前dp/dt值的55%和63%。用硝苯地平保护的心脏中LV腔僵硬度增加。指数常数m从0.04±0.01增加到0.08±0.01。I组再灌注后冠状动脉血流量从120增加到184毫升/100克/分钟(p<0.01)。III组的充血反应可忽略不计。在任何治疗组中,再灌注心肌的氧消耗均无显著改变。所有组在缺血期间及再灌注后的乳酸代谢相似。所有组的ATP值均显著降低(p<0.05)。缺血后即刻,I组、II组和III组的ATP分别为对照组的50%、28%和44%。维拉帕米对收缩功能的出色保存及生理性充血反应与高能化合物保存的改善或心肌氧消耗的显著变化无关。(摘要截短于250字)

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验